Health

Results: 3505-3516 of 8225

Owkin Launches ATLANTIS: An Extensive Multimodal Patient Data Discovery Program Across 7 Countries in 11 Therapeutic Areas

Cynosure Lutronic and Amico Aesthetics Join Forces by Signing a Strategic Distribution Agreement for the Middle East

PR Newswire associated0

EpiVax Strengthens Technology Leadership Amid Immunoinformatics Advancements

Astria Therapeutics Initiates ALPHA-ORBIT Phase 3 Pivotal Trial of Navenibart in Hereditary Angioedema

Tiziana Life Sciences Announces Groundbreaking Study Published in Nature Neuroscience Demonstrating Positive Results for Nasal Anti-CD3 Therapy in Traumatic Brain Injury

Silence Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update

(Graphic: Business Wire)

BeiGene Announces Fourth Quarter and Full Year 2024 Financial Results and Business Updates

PR Newswire associated0

New Data Shows NHS Burdened with 7.5 Million Hours of Extra Work Every Week

Business Wire embedded0

RDD Europe 2025, Co-Organized by Aptar Pharma and RDD Online, Celebrates 20 Years

Invitation to presentation of Sectra's nine-month interim report 2024/2025

Discover Equazen®, a science-based food supplement designed and studied to help nourish, enhance, and support the human brain’s potential across all life stages. (Graphic: Business Wire)

SFI Health™ EMEA Announces the Launch in Portugal of Equazen® Food Supplements, the Brand Developed to Support Cognitive Needs

PR Newswire associated0

The debate on MSCs is over; it's time to promote MSC therapy in practice